Липопротеины низкой плотности · Образование и функция · Роль в патологии · Поглощение клетками · Рекомендованные концентрации · Способы нормализации уровня ЛПНП · Близкие статьи · Примечания · Официальный сайт ·

1. [1]Segrest JP, Jones MK, De Loof H, Dashti N (September 2001). "Structure of apolipoprotein B-100 in low density lipoproteins". Journal of Lipid Research 42 (9): 1346–67. PMID 11518754.
2. Принципы лечения нарушений липидного обмена. И.А. Либов, Д.А. Иткин, С.В. Черкесова. РМАПО, Москва
3. Vasdev S, Gill V, Singal PK (2006). «Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms». Vasc Health Risk Manag 2 (3): 263–76. PMID 17326332.
4. Schuitemaker GE, Dinant GJ, van der Pol GA, van Wersch JW (2002). «Relationship between smoking habits and low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and triglycerides in a hypercholesterolemic adult cohort, in relation to gender and age». Clin Exp Med 2 (2): 83-8. PMID 12141531.
5. Dalmer Laboratory. Policosanol vs lovastatin: Comparative study on efficacy, safety and tolerability in the treatment of type-II hypercho-lesterolemia.
6. Benitez M., Romero C., Mas R. et al. (1997): A comparative study of policosanol vs pravastatin in patients with type-II hypercholester-olemia. Curr. Ther. Res. 58:859-67.
7. Ortensi G., Gladstein J., Vail H. and Tesone P.A. (1997): A comparativc study of policosanol vs. simvastatin in elderly patients with hypercho-lesterolemia. Curr. Ther. Res. 58:390-401.
8. Illnait J., Castano G., Mas R. and Fernandez J.C. (1997): A comparative study on the efficacy and tolerability of policosanol and simvastatin for treating type II hypercholesterolemia. Abstract front the 4th International Confereiicc on Preventive Cardiology. June 29-July 3. Can. J. Cardiol. 13:Suppl. B, 342B.